.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
McKesson
Chinese Patent Office
Boehringer Ingelheim
Dow
Argus Health
Harvard Business School
Julphar
Cipla
Queensland Health

Generated: July 27, 2017

DrugPatentWatch Database Preview

AVODART Drug Profile

« Back to Dashboard

What is the patent landscape for Avodart, and what generic Avodart alternatives are available?

Avodart is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in AVODART is dutasteride. There are seventeen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the dutasteride profile page.

Summary for Tradename: AVODART

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list49
Clinical Trials: see list18
Patent Applications: see list1,388
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AVODART at DailyMed

Pharmacology for Tradename: AVODART

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
AVODART
dutasteride
CAPSULE;ORAL021319-001Nov 20, 2001ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: AVODART

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
AVODART
dutasteride
CAPSULE;ORAL021319-001Nov 20, 2001► Subscribe► Subscribe
Glaxosmithkline
AVODART
dutasteride
CAPSULE;ORAL021319-001Nov 20, 2001► Subscribe► Subscribe
Glaxosmithkline
AVODART
dutasteride
CAPSULE;ORAL021319-001Nov 20, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: AVODART

Drugname Dosage Strength RLD Submissiondate
dutasterideCapsules0.5 mgAvodart10/29/2007
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Express Scripts
Cerilliant
Boehringer Ingelheim
Moodys
McKesson
Accenture
Farmers Insurance
Healthtrust
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot